Status:
UNKNOWN
Hyperinsulinemic Normoglycemic Clamp for Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborating Sponsors:
Astellas Pharma Canada, Inc.
Conditions:
Postoperative Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study proposes a simple and safe way of lowering this complicate rate, while improving graft recovering and protecting the graft as it recovers from the transplant. The investigators hypothesize ...
Eligibility Criteria
Inclusion
- Male or female patient over 18 years of age
- Patient is about to receive a pancreas or a simultaneous pancreas/kidney transplant
- Able to give written informed consent prior to any study specific procedure
Exclusion
- Multi-organ transplant other than kidney transplant
- No central venous access available to deliver the D20W solution
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01001273
Start Date
April 1 2010
End Date
June 1 2012
Last Update
March 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Royal Victoria
Montreal, Quebec, Canada, H3A1A1